» Articles » PMID: 36348718

Extracellular Vesicles Derived from Metastatic Melanoma Cells Transfer α7-nAChR MRNA, Thus Increasing the Surface Expression of the Receptor and Stimulating the Growth of Normal Keratinocytes

Overview
Journal Acta Naturae
Specialty Biology
Date 2022 Nov 9
PMID 36348718
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that extracellular vesicles secreted by metastatic melanoma cells stimulate the growth, migration, and stemness of normal keratinocytes. This study showed for the first time that extracellular vesicles secreted by the metastatic melanoma cell lines mel H, mel Kor, and mel P contain, both at the mRNA and protein levels, the α7-type nicotinic acetylcholine receptor (α7-nAChR), which is involved in the regulation of the oncogenic signaling pathways in epithelial cells. Incubation with the vesicles secreted by mel H cells and containing the highest amount of mRNA coding α7-nAChR increased the surface expression of α7-nAChR in normal Het-1A keratinocytes and stimulated their growth. Meanwhile, both of these effects disappeared in the presence of α-bungarotoxin, an α7-nAChR inhibitor. A bioinformatic analysis revealed a correlation between the increased expression of the CHRNA7 gene coding α7-nAChR in patients with metastatic melanoma and a poor survival prognosis. Therefore, extracellular vesicles derived from metastatic melanoma cells can transfer mRNA coding α7-nAChR, thus enhancing the surface expression of this receptor and stimulating the growth of normal keratinocytes. Targeting of α7-nAChR may become a new strategy for controlling the malignant transformation of keratinocytes.

Citing Articles

Extracellular vesicles from cancer cell lines of different origins drive the phenotype of normal oral fibroblasts in a CAF-like direction.

Soland T, Lipka A, Ruus A, Molvaersmyr A, Galtung H, Haug T Front Oncol. 2024; 14:1456346.

PMID: 39381039 PMC: 11458688. DOI: 10.3389/fonc.2024.1456346.


α5-nAChR/ADAM10 signaling mediates nicotine-related cutaneous melanoma progression via STAT3 activation.

Li X, Meng X, Fan H, Wang Y, Jia Y, Jiao J Arch Dermatol Res. 2024; 316(6):269.

PMID: 38795191 DOI: 10.1007/s00403-024-03110-0.

References
1.
Falcone I, Conciatori F, Bazzichetto C, Ferretti G, Cognetti F, Ciuffreda L . Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy. Cancers (Basel). 2020; 12(10). PMC: 7601592. DOI: 10.3390/cancers12102870. View

2.
Boussadia Z, Lamberti J, Mattei F, Pizzi E, Puglisi R, Zanetti C . Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules. J Exp Clin Cancer Res. 2018; 37(1):245. PMC: 6173926. DOI: 10.1186/s13046-018-0915-z. View

3.
Dratkiewicz E, Simiczyjew A, Mazurkiewicz J, Zietek M, Matkowski R, Nowak D . Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance. Cells. 2021; 10(4). PMC: 8070386. DOI: 10.3390/cells10040862. View

4.
Goldman M, Craft B, Hastie M, Repecka K, McDade F, Kamath A . Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020; 38(6):675-678. PMC: 7386072. DOI: 10.1038/s41587-020-0546-8. View

5.
Lyukmanova E, Bychkov M, Sharonov G, Efremenko A, Shulepko M, Kulbatskii D . Human secreted proteins SLURP-1 and SLURP-2 control the growth of epithelial cancer cells via interactions with nicotinic acetylcholine receptors. Br J Pharmacol. 2018; 175(11):1973-1986. PMC: 5980222. DOI: 10.1111/bph.14194. View